3,589 reports of this reaction
4.8% of all CICLESONIDE reports
#3 most reported adverse reaction
WHEEZING is the #3 most commonly reported adverse reaction for CICLESONIDE, manufactured by Covis Pharma US, Inc. There are 3,589 FDA adverse event reports linking CICLESONIDE to WHEEZING. This represents approximately 4.8% of all 74,022 adverse event reports for this drug.
Patients taking CICLESONIDE who experience wheezing should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WHEEZING is moderately reported among CICLESONIDE users, representing a notable but not dominant share of adverse events.
In addition to wheezing, the following adverse reactions have been reported for CICLESONIDE:
The following drugs have also been linked to wheezing in FDA adverse event reports:
WHEEZING has been reported as an adverse event in 3,589 FDA reports for CICLESONIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
WHEEZING accounts for approximately 4.8% of all adverse event reports for CICLESONIDE, making it one of the most commonly reported side effect.
If you experience wheezing while taking CICLESONIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.